You are here: Industry Insights > Drug

News List

Fully automated facility for drug discovery to be built in UK pharmatimes
June 13, 2018
The UK Government has revealed plans to build a fully automated facility at the Rosalind Franklin Institute in Oxfordshire to enable fast, effective and hands-free molecular discovery for new medicines.
Trial suggests KaNDy’s menopause drug could be better than HRT fiercebiotech
June 11, 2018
New women’s health biotech KaNDy Therapeutics—rumored to have attracted buyout interest from Allergan—has just reported data on its lead product that could enhance its allure.
"Underwhelming" drug data devastates Nektar, shares fall by 42% pharmafile
June 07, 2018
Nektar Therapeutics has seen its share price devastated after revealing disappointing trial data for its candidate NKTR-214 in combination with Bristol Myers-Squibb’s Opdivo at the American Society of Clinical Oncology (ASCO) annual event in Chicago.
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation worldpharmanews
June 05, 2018
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.
Soy lecithin NSAID combo drug protects against cancer with fewer side effects worldpharmanews
June 05, 2018
When scientists at The University of Texas Health Science Center at Houston (UTHealth) applied a chemical found in soybeans to a non-steroidal anti-inflammatory drug (NSAID)
Novo Nordisk’s oral diabetes drug beats Jardiance in study financialexpress
June 01, 2018
Novo Nordisk has announced that data from a large final-stage study of a pill. The company hopes it will transform the diabetes market proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s established Jardiance.
Celldex plans life after glembatumumab, cutting 2 more drugs from pipeline fiercebiotech
May 16, 2018
Still reeling from the failure of its lead breast cancer candidate glembatumumab vedotin last month, Celldex has culled another two pipeline projects and now says it will focus its R&D efforts mainly on two cancer antibodies.
News of Note—A drug to reduce age-related stomach damage; a CAR-T to attack colon tumors fiercebiotech
May 08, 2018
Scientists at the Massachusetts Institute of Technology have discovered in mouse experiments that a decline in intestinal stem cells that typically occurs during aging can be reversed with 24 hours of fasting...
Patent fights jump in 2017 as Eli Lilly, Pfizer, Sanofi and more sue to protect their meds fiercepharma
May 07, 2018
In the ever-raging war between generic drugmakers and branded pharma, patent litigation is a standard-issue weapon. It's a high-stakes business as generics makers aim to grow their sales by rolling out copies of blockbuster drugs...
Catalent Bolsters Drug Development Capabilities contractpharma
April 25, 2018
Catalent Pharma Solutions has unveiled plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, NJ facility and headquarters.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page